Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Sarcoma 1Breast 1

Conditions

Pain, Postoperative 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Bites and Stings 1Agnosia 1

Interventions

pembrolizumab 1270Specimen Handling 921Magnetic Resonance Spectroscopy 832Carboplatin 829Cyclophosphamide 802Cisplatin 726Nivolumab 682Paclitaxel 639Radiotherapy 613Gemcitabine 578Biopsy 556Bevacizumab 477Dexamethasone 445fludarabine 405Docetaxel 382venetoclax 372Oxaliplatin 365Capecitabine 360Fluorouracil 358atezolizumab 345durvalumab 338Rituximab 336Drug Therapy 330Doxorubicin 319Radiosurgery 316Blood Specimen Collection 313Pemetrexed 308Standard of Care 306Ipilimumab 305Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Surgical Instruments × 1 year × Clear all
NCT07581977 2026-05-22

A Novel Two-Tooth Clip for ESD and EFTR of GIST

Affiliated Hospital to Academy of Military Medical Sciences

Phase NA Recruiting
60 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT05478538 2026-04-29

CYBRID-01

Elephas

Active not recruiting
200 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07388953 2026-02-13

BAPTAP

Faculdade de Ciências Médicas de Minas Gerais

Phase NA Recruiting
140 enrolled
Gastrointestinal

Agnosia, Bites and Stings, Pain, Postoperative, Colorectal Neoplasms

NCT06294574 2025-09-22

Improved Successful Retrieval Rate of HydroMARK Plus Breast Biopsy Site Marker in Comparison to HydroMARK as Well as Improved Surgeon Satisfaction

University of Alabama at Birmingham

Phase NA Recruiting
150 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡